BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 15123609)

  • 1. A conserved DpYR motif in the juxtamembrane domain of the Met receptor family forms an atypical c-Cbl/Cbl-b tyrosine kinase binding domain binding site required for suppression of oncogenic activation.
    Peschard P; Ishiyama N; Lin T; Lipkowitz S; Park M
    J Biol Chem; 2004 Jul; 279(28):29565-71. PubMed ID: 15123609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation of the c-Cbl TKB domain binding site on the Met receptor tyrosine kinase converts it into a transforming protein.
    Peschard P; Fournier TM; Lamorte L; Naujokas MA; Band H; Langdon WY; Park M
    Mol Cell; 2001 Nov; 8(5):995-1004. PubMed ID: 11741535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural characterization of a novel Cbl phosphotyrosine recognition motif in the APS family of adapter proteins.
    Hu J; Hubbard SR
    J Biol Chem; 2005 May; 280(19):18943-9. PubMed ID: 15737992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Cbl is involved in Met signaling in B cells and mediates hepatocyte growth factor-induced receptor ubiquitination.
    Taher TE; Tjin EP; Beuling EA; Borst J; Spaargaren M; Pals ST
    J Immunol; 2002 Oct; 169(7):3793-800. PubMed ID: 12244174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An adjacent arginine, and the phosphorylated tyrosine in the c-Met receptor target sequence, dictates the orientation of c-Cbl binding.
    Sun Q; Ng C; Guy GR; Sivaraman J
    FEBS Lett; 2011 Jan; 585(2):281-5. PubMed ID: 21163258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of stem cell factor receptor signaling by Cbl family proteins (Cbl-b/c-Cbl).
    Zeng S; Xu Z; Lipkowitz S; Longley JB
    Blood; 2005 Jan; 105(1):226-32. PubMed ID: 15315962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of ubiquitin protein ligase activity in c-Cbl by phosphorylation-induced conformational change and constitutive activation by tyrosine to glutamate point mutations.
    Kassenbrock CK; Anderson SM
    J Biol Chem; 2004 Jul; 279(27):28017-27. PubMed ID: 15117950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Additional serine/threonine phosphorylation reduces binding affinity but preserves interface topography of substrate proteins to the c-Cbl TKB domain.
    Sun Q; Jackson RA; Ng C; Guy GR; Sivaraman J
    PLoS One; 2010 Sep; 5(9):e12819. PubMed ID: 20877636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor.
    Lill NL; Douillard P; Awwad RA; Ota S; Lupher ML; Miyake S; Meissner-Lula N; Hsu VW; Band H
    J Biol Chem; 2000 Jan; 275(1):367-77. PubMed ID: 10617627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct recruitment of Eps15 via Its coiled-coil domain is required for efficient down-regulation of the met receptor tyrosine kinase.
    Parachoniak CA; Park M
    J Biol Chem; 2009 Mar; 284(13):8382-94. PubMed ID: 19109251
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SLAP2 Adaptor Binding Disrupts c-CBL Autoinhibition to Activate Ubiquitin Ligase Function.
    Wybenga-Groot LE; Tench AJ; Simpson CD; Germain JS; Raught B; Moran MF; McGlade CJ
    J Mol Biol; 2021 Apr; 433(8):166880. PubMed ID: 33617900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-Cbl binds the CSF-1 receptor at tyrosine 973, a novel phosphorylation site in the receptor's carboxy-terminus.
    Wilhelmsen K; Burkhalter S; van der Geer P
    Oncogene; 2002 Feb; 21(7):1079-89. PubMed ID: 11850825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ubiquitin ligase activity of c-Cbl guides the epidermal growth factor receptor into clathrin-coated pits by two distinct modes of Eps15 recruitment.
    de Melker AA; van der Horst G; Borst J
    J Biol Chem; 2004 Dec; 279(53):55465-73. PubMed ID: 15465819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The linker phosphorylation site Tyr292 mediates the negative regulatory effect of Cbl on ZAP-70 in T cells.
    Rao N; Lupher ML; Ota S; Reedquist KA; Druker BJ; Band H
    J Immunol; 2000 May; 164(9):4616-26. PubMed ID: 10779765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cbl-c suppresses v-Src-induced transformation through ubiquitin-dependent protein degradation.
    Kim M; Tezuka T; Tanaka K; Yamamoto T
    Oncogene; 2004 Mar; 23(9):1645-55. PubMed ID: 14661060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosine phosphorylation of Sprouty2 enhances its interaction with c-Cbl and is crucial for its function.
    Fong CW; Leong HF; Wong ES; Lim J; Yusoff P; Guy GR
    J Biol Chem; 2003 Aug; 278(35):33456-64. PubMed ID: 12815057
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct binding of Cbl to Tyr568 and Tyr936 of the stem cell factor receptor/c-Kit is required for ligand-induced ubiquitination, internalization and degradation.
    Masson K; Heiss E; Band H; Rönnstrand L
    Biochem J; 2006 Oct; 399(1):59-67. PubMed ID: 16780420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Met/Hepatocyte growth factor receptor ubiquitination suppresses transformation and is required for Hrs phosphorylation.
    Abella JV; Peschard P; Naujokas MA; Lin T; Saucier C; Urbé S; Park M
    Mol Cell Biol; 2005 Nov; 25(21):9632-45. PubMed ID: 16227611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Negative regulation of Lck by Cbl ubiquitin ligase.
    Rao N; Miyake S; Reddi AL; Douillard P; Ghosh AK; Dodge IL; Zhou P; Fernandes ND; Band H
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3794-9. PubMed ID: 11904433
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative regulation of receptor tyrosine kinases by ubiquitination: Key roles of the Cbl family of E3 ubiquitin ligases.
    Tang R; Langdon WY; Zhang J
    Front Endocrinol (Lausanne); 2022; 13():971162. PubMed ID: 35966060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.